(DEL AM)
18 Agosto 2017 - 12:05PM
Edgar (US Regulatory)
BIOSTAGE, INC.
84 October Hill Road, Suite 11
Holliston, Massachusetts 01746
August 17, 2017
VIA EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Registration Statement on Form S-1
Filed August 15, 2017
File No. 333-219978
Ladies and Gentlemen:
This letter follows your voicemail to our
outside counsel regarding the above-referenced registration statement on Form S-1 that was filed by Biostage, Inc. on August 15,
2017. Please accept this letter as an amendment to the registration statement to include the delaying amendment language
required by Securities and Exchange Commission Rule 473 as follows:
“The registrant hereby amends
this registration statement on such date or dates as may be necessary to delay its effective date until the registrant shall file
a further amendment which specifically states that this registration statement shall thereafter become effective in accordance
with section 8(a) of the Securities Act of 1933 or until the registration statement shall become effective on such
date as the Commission, acting pursuant to said section 8(a), may determine.”
We appreciate the staff’s comments,
and request that the staff contact Chad J. Porter, Esq. at (617) 345-3686 or via email at cporter@burnslev.com with any questions
or comments.
|
BIOSTAGE, INC.
|
|
|
|
By:
|
/s/ James McGorry
|
|
|
James McGorry
|
|
|
Chief Executive Officer
|
|
cc:
|
Josef B. Volman, Esq., Burns & Levinson LLP
|
jvolman@burnslev.com
Chad J. Porter, Esq., Burns & Levinson LLP
cporter@burnslev.com
Grafico Azioni Biostage (QB) (USOTC:BSTG)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni Biostage (QB) (USOTC:BSTG)
Storico
Da Giu 2023 a Giu 2024
Notizie in Tempo Reale relative a Biostage Inc (QB) (OTCMarkets): 0 articoli recenti
Più Biostage, Inc. Articoli Notizie